Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hudson Securities was a full-service investment bank and broker-dealer that provided a wide range of financial services, including institutional sales, trading, and investment banking. The firm was particularly recognized for its research coverage and market-making activities within the healthcare, life sciences, and technology sectors. In 2011, Hudson Securities was acquired by Rodman & Renshaw Capital Group, a firm that also maintained a significant focus on the life sciences industry. Prior to its acquisition, Hudson Securities was a prominent player in providing capital markets solutions and advisory services to emerging growth companies in the biotech and pharmaceutical space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hudson Securities.